{
    "code": "51058580",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=51058580",
    "time": "2023-04-21 03:40:35",
    "許可證字號": "衛部藥製字第058580號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "114\/01\/20",
    "發證日期": "104\/01\/20",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原登錄字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHY05105858005",
    "中文品名": "派癌休注射劑",
    "英文品名": "Pexeda Injection",
    "適應症": "1.\t併用cisplatin是治療局部晚期或轉移性非小細胞肺癌(顯著鱗狀細胞組織型除外)之第一線化療用藥。\r\n2.\t單一藥物是局部晚期或轉移性非小細胞肺癌(顯著鱗狀細胞組織型除外)病人接受4個週期含鉑藥物的第一線化療後疾病並未惡化之維持療法。\r\n3.\t單一藥物是治療局部晚期或轉移性非小細胞肺癌(顯著鱗狀細胞組織型除外)之第二線治療用藥。\r\n4.\t與pembrolizumab及含鉑化學療法併用，做為轉移性，不具有EGFR或ALK腫瘤基因異常之非鱗狀非小細胞肺癌的第一線治療藥物。\r\n5.\t與cisplatin併用於治療惡性肋膜間質細胞瘤。",
    "劑型": "270注射劑",
    "包裝": "100毫克小瓶裝 500毫克小瓶裝 100支以下盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "Pemetrexed disodium 2.5 hydrate",
    "限制項目": "01國　產 26監視期滿新藥",
    "申請商名稱": "6201125122  台灣東洋藥品工業股份有限公司",
    "申請商地址": "台北市南港區園區街3之1號3樓",
    "主製造廠": [
        {
            "製造廠名稱": "1406804300  臺灣東洋藥品工業股份有限公司中壢廠",
            "製造廠廠址": "桃園市中壢區中華路一段８３８號",
            "製造廠公司地址": "",
            "製造廠國別": "TAIWAN",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "1004002420",
            "成分名稱": "Pemetrexed disodium 2.5 hydrate",
            "含量描述": "equal to Pemetrexed 25mg",
            "含量": "30.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "010585800004 藥物外觀 500mg-104-09-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058580&Seq=002&Type=10"
        },
        {
            "title": "010585800004 藥物外觀 100mg-104-09-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058580&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "010585800001 仿單-104-09-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058580&Seq=002&Type=9"
        },
        {
            "title": "Pexeda Injcetion 標籤(500mg,20ml)-2LB01316(A01)-109-01-08.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058580&Seq=022&Type=8"
        },
        {
            "title": "Pexeda Injcetion 標籤(100mg,4ml)-2LB01315(A01)-109-01-08.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058580&Seq=021&Type=8"
        },
        {
            "title": "Pexeda Injcetion 外盒(500mg,20ml)-2CT01316(A02)-109-01-08.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058580&Seq=020&Type=8"
        },
        {
            "title": "Pexeda Injcetion 外盒(100mg,4ml)-2CT01315(A02)-109-01-08.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058580&Seq=019&Type=8"
        },
        {
            "title": "Pexeda Injcetion 標籤(500mg,20ml)-2LB01316(A01)-108-03-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058580&Seq=015&Type=8"
        },
        {
            "title": "Pexeda Injcetion 標籤(100mg,4ml)-2LB01315(A010-108-03-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058580&Seq=014&Type=8"
        },
        {
            "title": "Pexeda Injcetion 外盒(500mg,20ml)-2CT01316(A01)-108-03-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058580&Seq=013&Type=8"
        },
        {
            "title": "Pexeda Injcetion 外盒(100mg,4ml)-2CT01315(A01)-108-03-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058580&Seq=012&Type=8"
        },
        {
            "title": "Pexeda Injcetion 標籤(500mg,20ml)-2LB01316(A01)-108-03-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058580&Seq=018&Type=8"
        },
        {
            "title": "Pexeda Injcetion 標籤(100mg,4ml)-2LB01315(A010-108-03-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058580&Seq=017&Type=8"
        },
        {
            "title": "Pexeda Injcetion 外盒(100mg,4ml)-2CT01315(A01)-108-03-26(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058580&Seq=016&Type=8"
        },
        {
            "title": "010585800003 外盒500mg-104-09-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058580&Seq=008&Type=8"
        },
        {
            "title": "010585800003 外盒100mg-104-09-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058580&Seq=007&Type=8"
        },
        {
            "title": "010585800002 瓶標 500mg-104-09-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058580&Seq=006&Type=8"
        },
        {
            "title": "010585800002 瓶標 100mg-104-09-24(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=51058580&Seq=005&Type=8"
        }
    ]
}